Sandoz is offering a generic paclitaxel formulation, which is the first FDA-approved ANDA to BioScience’s Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable ...

The data hint at sirolimus becoming a useful option or even a replacement for paclitaxel, but full 5-year follow-up is needed ...

The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...

Oncolytics Biotech (TSE:ONC) has released an update. Oncolytics Biotech reported positive results for its pelareorep and paclitaxel combination, showing significant improvements in survival rates for ...

The contest between the two main classes of antiproliferatives for circulatory system use continues as seen in a presentation ...

Medically reviewed by Arno Kroner, DAOM Damiana, scientifically known as Turnera diffusa or Turnera aphrodisiaca, is a ...

Qilu Pharmaceutical, the licensee of certepetide in the Greater China territory, is currently evaluating certepetide in combination with gemcitabine and nab-paclitaxel as a treatment for mPDAC. During ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

From a casual observer to a cancer campaigner, Diane Coetzer shares her insights on the physical and emotional challenges of ...

Th e GINECO trial explored the combination of trastuzumab with paclitaxel and carboplatin in patients with resistant AOC (< 6 months) and HER2 gene amplification. Patients and Methods: A total of ...